Summary:
- This article discusses the use of a new vaccine approach called "self-assembling protein nanoparticles" to protect against influenza viruses.
- The vaccine uses a protein from the influenza virus that spontaneously assembles into nanoparticles, which are then combined with an adjuvant to enhance the immune response.
- Experiments in animal models showed that this vaccine provided broad protection against different strains of influenza, suggesting it could be a promising universal flu vaccine candidate.